JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,854,000 | -22.8% | 2,928,900 | 0.0% | 0.13% | -21.1% |
| Q2 2022 | $8,875,000 | -54.3% | 2,928,900 | +2.4% | 0.16% | -48.9% |
| Q1 2022 | $19,419,000 | -18.7% | 2,859,900 | 0.0% | 0.32% | +2.6% |
| Q4 2021 | $23,880,000 | +21.0% | 2,859,900 | +7.7% | 0.31% | +41.5% |
| Q3 2021 | $19,731,000 | +35.1% | 2,655,600 | +23.7% | 0.22% | +46.6% |
| Q2 2021 | $14,602,000 | -22.0% | 2,147,400 | +17.8% | 0.15% | -15.4% |
| Q1 2021 | $18,728,000 | – | 1,823,600 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $228,648,000 | 42.85% |
| Pharmstandard International S.A. | 662,063 | $14,797,000 | 37.17% |
| TRV GP III, LLC | 3,048,780 | $68,140,000 | 24.53% |
| Omega Fund Management, LLC | 529,965 | $11,845,000 | 11.64% |
| Casdin Capital, LLC | 635,000 | $14,192,000 | 2.50% |
| Virtus ETF Advisers LLC | 58,867 | $1,316,000 | 1.14% |
| Redmile Group, LLC | 1,182,393 | $26,426,000 | 1.02% |
| PFM Health Sciences, LP | 1,923,651 | $42,994,000 | 0.87% |
| Elephas Investment Management Ltd | 154,400 | $3,451,000 | 0.63% |
| Ghost Tree Capital, LLC | 125,092 | $2,796,000 | 0.57% |